Clinical Trial Update: The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo [Phase 1, Phase 2]

View source ↗

Summary

This document reports an update on a Phase 1/2 trial evaluating the safety and immunogenicity of the DNA-GTU vaccine in HIV-infected adults on antiretroviral th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DNA-GTU vaccine (DNA-GTU vaccine)

Snippet

Sponsor: Imperial College London | Conditions: HIV | Phase 1, Phase 2 | Status: COMPLETED